1. A shelving display system comprising:
a back wall;
a first side wall extending from a first side of the back wall toward a front portion of the display system;
a second side wall extending from a second side of the back wall toward a front portion of the display system; and,
a plurality of shelves formed from a first shelf component and a second shelf component extending between the first side wall and the second side wall, the first shelf component provided by a first shelf panel extending between the first side wall and the second side wall approximately midway from the back wall to the front portion of the display system wherein the first shelf panel is integrally connected to a strip of material glued to an interior surface of one of the first and second side walls, and the second shelf component provided by a second shelf panel extending between the first side wall and the second side wall proximate the front portion of the display system.
2. The shelving display of claim 1 wherein the first shelf panel is integrally connected to a positioning panel that positions the first shelf panel at the midway portion of the first and second side walls.
3. The shelving display of claim 2 wherein an interior surface of one of the first and second side walls is glued to an exterior surface of the positioning panel.
4. The shelving display system of claim 1 wherein the back wall, side walls, and plurality of shelves are formed from a corrugated material.
5. The shelving display system of claim 4 wherein the back wall, side walls, and plurality of shelves are formed from a single blank of material.
6. The shelving display of claim 5 wherein the single blank of material is formed from corrugated cardboard.
7. The shelving display of claim 5 wherein the single blank of material is formed from plastic.
8. The shelving display of claim 1 wherein the first shelf component includes a slot, and the second shelf component includes a tab positioned to interlock with the slot of the first shelf component.
9. The shelving display system of claim 1 wherein each shelf includes a vertically positioned front panel.
10. A stand-alone shelving display comprising:
a single blank of corrugated material foldable to include:
a back wall,
a first side wall positioned on a first side of the back wall,
a second side wall positioned on a second side of the back wall,
a plurality of shelves extending between the first side wall and the second side wall, the plurality of shelves formed from a first shelf panel having a plurality of first shelf components and a second shelf panel having a plurality of second shelf components configured to interlock with the first shelf components, and
a positioning panel integrally connected on a first side to the first shelf panel and integrally connected on a second side to the back wall wherein the positioning panel is foldable to position the first shelf panel approximately to a middle portion of the first and second side walls.
11. The stand-alone shelving display of claim 10 wherein the first shelf component includes a slot and the second shelf component includes a tab positioned for insertion into the slot to interlock the components.
12. A blank of corrugated material for creating a shelving display system having two part shelves, the blank comprising:
a back wall panel integrally connected on a first side to a first side of a positioning panel, the positioning panel integrally connected on a second side to a first side of a first shelf panel, the back panel integrally connected on a second side to a first side of a first side wall panel, the first side wall panel integrally connected on a second side to a first side of a second shelf panel, and the second shelf panel integrally connected on a second side to a first side of a second side wall panel, wherein the first shelf panel includes a plurality of first shelf components and the second shelf panel includes a plurality of second shelf components and wherein each of the plurality of second shelf components of the second shelf panel cooperate with a corresponding one of the plurality of first shelf components of the first shelf panel to form a plurality of shelves for the display system.
13. The blank of claim 12 further comprising a glue strip panel integrally connected to a second side of the first shelf panel.
14. The blank of claim 12 wherein each of the plurality of first shelf components form a portion of the shelf proximate the back wall panel.
15. The blank of claim 14 wherein each of the plurality of first shelf components include a slot proximate a front portion of the first shelf component and each of the second shelf components include a tab that cooperates with a corresponding slot in a first shelf component to secure the second shelf component to the first shelf component.
16. The blank of claim 15 further comprising a glue panel connected to a second side of the first shelf panel, the glue panel being configured to secure the first shelf panel to an interior portion of the first side wall panel.
17. A shelving display system comprising:
a back wall;
a first side wall extending from a first side of the back wall toward a front portion of the display system;
a second side wall extending from a second side of the back wall toward a front portion of the display system; and,
a plurality of shelves formed from a first shelf component and a second shelf component extending between the first side wall and the second side wall, the first shelf component provided by a first shelf panel extending between the first side wall and the second side wall approximately midway from the back wall to the front portion of the display system wherein the first shelf panel is integrally connected to a positioning panel that positions the first shelf panel at the midway portion of the first and second side walls, and the second shelf component provided by a second shelf panel extending between the first side wall and the second side wall proximate the front portion of the display system.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. An anti-neoplastic product comprising: a first anti-neoplastic dosage form, a second anti-neoplastic dosage form, and a third anti-neoplastic dosage form, each of said first, second and third anti-neoplastic dosage forms comprising an anti-neoplastic and a pharmaceutically acceptable carrier, said three dosage forms having different release profiles, said anti-neoplastic product reaching a Cmax in less than about twelve hours after initial release of anti-neoplastic and each being a delayed release dosage form.
2. The product of claim 1 wherein the first dosage form is an immediate release dosage form.
3. The product of claim 2 wherein the Cmax for the product is reached no earlier than four hours after initial release of anti-neoplastic.
4. The product of claim 2 wherein the first dosage form contains at least 20% and no more than 50% of the total dosage of anti-neoplastic.
5. The product of claim 4 wherein the product is an oral dosage form.
6. The product of claim 5 wherein the anti-neoplastic released from the second dosage form reaches a Cmax in the serum after Cmax is reached in the serum for anti-neoplastic released from the first dosage form.
7. The product of claim 6 wherein the anti-neoplastic released from the third dosage form reaches a Cmax in the serum after the anti-neoplastic released from the second dosage form reaches a Cmax in the serum.
8. The anti-neoplastic product of claim 1 wherein said anti-neoplastic product includes a total dosage of anti-neoplastic that is effective for a twenty four hour period.
9. The product of claim 1 and further comprising a fourth anti-neoplastic dosage form comprising an anti-neoplastic and a pharmaceutically acceptable carrier, wherein anti-neoplastic released from the fourth dosage form reaches a Cmax in the serum after Cmax is achieved in the serum for anti-neoplastic released from each of the first, second and third dosage forms.
10. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 1.
11. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 2.
12. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 3.
13. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 4.
14. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 5.
15. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 6.
16. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 7.
17. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 8.
18. A process for treating cancer in a host comprising:
administering to a host the anti-neoplastic product of claim 9.
19. An anti-neoplastic product comprising: a first anti-neoplastic dosage form, a second anti-neoplastic dosage form, and a third anti-neoplastic dosage form, each of said first, second and third anti-neoplastic dosage forms comprising an anti-neoplastic and a pharmaceutically acceptable carrier, said three dosage forms having different release profiles, said anti-neoplastic product reaching a Cmax in less than about twelve hours after initial release of anti-neoplastic from the product, said first, second and third dosage forms, each being a delayed release dosage form, wherein the anti-neoplastic released from the first dosage form reaches a Cmax in serum in from 0.5 to 2 hours after initial release of anti-neoplastic from the product, wherein the anti-neoplastic released from the second dosage form reaches a Cmax in serum in no more than about 4 hours after initial release of anti-neoplastic from the product and after Cmax is reached for anti-neoplastic from the first dosage form and the anti-neoplastic released from the third dosage form reaches a Cmax in serum after the Cmax is reached for the anti-neoplastic released from the second dosage form.
20. The product of claim 19 wherein the second dosage form initiates release of the anti-neoplastic at least one hour after the first dosage form.
21. The product of claim 20 wherein the Cmax for the second dosage form is reached no earlier than two hours after initial release of anti-neoplastic from the product.
22. The product of claim 21 wherein the first dosage form contains from about 20% to about 50%, by weight, of the total anti-neoplastic of the product, wherein the second dosage form contains from 30% to 60%, by weight, of the anti-neoplastic that is contained in the second and third dosage forms.
23. The product of claim 22 wherein the first dosage form contains from 15% to 30%, by weight, of the total anti-neoplastic present in the product.
24. The product of claim 22 wherein the product includes a fourth delayed release anti-neoplastic dosage form having a different release profile from the first, second and third dosage forms and Cmax for the fourth dosage form is reached after Cmax for each of the first, second and third dosage forms.
25. The product of claim 24 wherein the second dosage form contains from 20% to 35%, by weight, of the total anti-neoplastic present in the second, third and fourth dosage forms, the third dosage form contains from 20% to 40%, by weight, of the total anti-neoplastic present in the second, third and fourth dosage forms, with the remainder being present in the fourth dosage form.
26. The product of claim 19 wherein Cmax for the product is reached no earlier than four hours after initial release of anti-neoplastic.
27. The product of claim 26 wherein Cmax in serum for the second dosage form is reached within 8 hours after initial release of anti-neoplastic from the product.